Publication | Closed Access
Vasopressin V <sub>2</sub> -Receptor Blockade With Tolvaptan in Patients With Chronic Heart Failure
430
Citations
11
References
2003
Year
In patients with CHF, tolvaptan was well tolerated; it reduced body weight and edema and normalized serum sodium in the hyponatremic patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1